Skip to content
2000
Volume 17, Issue 2
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Adolescence is an immature but adventurous time period of exploration. Due to rapid developments of the brain with unbalanced release of neurotransmitters, adolescents are prone to impulsivity that may carry out potentially dangerous behaviors. According to the Centers for Disease Control and Prevention, more than one-third of high school students have reported the use of cannabis or marijuana in 2019, and the trend has not declined since. Previous studies have shown that cannabis not only affects cognitive and social behaviors, but also produces psychological responses to stress. In this review, we have summarized recent studies on cannabis-produced effects during the unique period of adolescent development, and we have also briefly discussed the legalization of cannabis. Though there are slight differences between cannabis and marijuana, the major active component of them is tetrahydrocannabinol. We have used the term “cannabis” in this review. Cannabis use in adolescents causes structural and functional changes in the brain, increasing the probability of depression, which is also associated with other illicit substance use, and impairs education achievement. Given that cannabis use can cause detrimental harm to adolescents, it is suggested that adolescents should generally avoid using cannabis in a recreational manner. More preclinical and clinical studies are needed to provide detailed information for evidence-based decisions.

© 2025 The Author(s). Published by Bentham Science Publishers. 
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775273727231224185028
2024-01-15
2025-09-30

  • From This Site

    /content/journals/cdrr/10.2174/0125899775273727231224185028
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cdrr/17/2/CDRR-17-2-05.html?itemId=/content/journals/cdrr/10.2174/0125899775273727231224185028&mimeType=html&fmt=ahah

References

  1. ColizziM. BhattacharyyaS. Cannabis: Neuropsychiatry and its effects on brain and behavior.Brain Sci.2020101183410.3390/brainsci1011083433182671
     [Google Scholar]
  2. HuestisM.A. Cannabis (Marijuana) - Effects on human performance and behavior.Forensic Sci. Rev.2002141-2156026256486
     [Google Scholar]
  3. SharmaP. MurthyP. BharathM.M. Chemistry, metabolism, and toxicology of cannabis: Clinical implications.Iran. J. Psychiatry20127414915623408483
     [Google Scholar]
  4. BonnieR.J. ScottE.S. The teenage brain.Curr. Dir. Psychol. Sci.201322215816110.1177/0963721412471678
     [Google Scholar]
  5. LazorT. BlondalE. ScheimA. CubillosP. WerbD. MilloyM.J. BonatoS. MaghsoudiN. RuedaS. Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains.Drug Alcohol Depend.202223610946310.1016/j.drugalcdep.2022.10946335594643
     [Google Scholar]
  6. GaliègueS. MaryS. MarchandJ. DussossoyD. CarrièreD. CarayonP. BouaboulaM. ShireD. LE FurG. CasellasP. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.Eur. J. Biochem.19952321546110.1111/j.1432‑1033.1995.tb20780.x7556170
     [Google Scholar]
  7. NocerinoE. AmatoM. IzzoA.A. Cannabis and cannabinoid receptors.Fitoterapia200071Suppl. 1S6S1210.1016/S0367‑326X(00)00171‑410930707
     [Google Scholar]
  8. KendallD.A. YudowskiG.A. Cannabinoid receptors in the central nervous system: Their signaling and roles in disease.Front. Cell. Neurosci.20171029410.3389/fncel.2016.0029428101004
     [Google Scholar]
  9. PertweeR.G. The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin.Br. J. Pharmacol.2008153219921510.1038/sj.bjp.070744217828291
     [Google Scholar]
  10. ThomasA. BaillieG.L. PhillipsA.M. RazdanR.K. RossR.A. PertweeR.G. Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro.Br. J. Pharmacol.2007150561362310.1038/sj.bjp.070713317245363
     [Google Scholar]
  11. ThamM. YilmazO. AlaverdashviliM. KellyM.E.M. Denovan-WrightE.M. LaprairieR.B. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors.Br. J. Pharmacol.2019176101455146910.1111/bph.1444029981240
     [Google Scholar]
  12. Martínez-PinillaE. VaraniK. Reyes-ResinaI. AngelatsE. VincenziF. Ferreiro-VeraC. OyarzabalJ. CanelaE.I. LanciegoJ.L. NadalX. NavarroG. BoreaP.A. FrancoR. Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors.Front. Pharmacol.2017874410.3389/fphar.2017.0074429109685
     [Google Scholar]
  13. LaprairieR.B. BagherA.M. KellyM.E.M. Denovan-WrightE.M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor.Br. J. Pharmacol.2015172204790480510.1111/bph.1325026218440
     [Google Scholar]
  14. GalajE. XiZ.X. Possible receptor mechanisms underlying cannabidiol effects on addictive-like behaviors in experimental animals.Int. J. Mol. Sci.202022113410.3390/ijms2201013433374481
     [Google Scholar]
  15. SarozY. KhoD.T. GlassM. GrahamE.S. GrimseyN.L. Cannabinoid receptor 2 (CB 2 ) signals via G-alpha-s and induces IL-6 and IL-10 cytokine secretion in human primary leukocytes.ACS Pharmacol. Transl. Sci.20192641442810.1021/acsptsci.9b0004932259074
     [Google Scholar]
  16. GlassM. FelderC.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor.J. Neurosci.199717145327533310.1523/JNEUROSCI.17‑14‑05327.19979204917
     [Google Scholar]
  17. BlázquezC. ChiarloneA. BellocchioL. ReselE. PruunsildP. García-RincónD. SendtnerM. TimmuskT. LutzB. Galve-RoperhI. GuzmánM. The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.Cell Death Differ.201522101618162910.1038/cdd.2015.1125698444
     [Google Scholar]
  18. PalazuelosJ. AguadoT. EgiaA. MechoulamR. GuzmánM. Galve-RoperhI. PalazuelosJ. AguadoT. EgiaA. MechoulamR. GuzmánM. Galve-RoperhI. Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation.FASEB J.200620132405240710.1096/fj.06‑6164fje17015409
     [Google Scholar]
  19. ZouS. KumarU. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system.Int. J. Mol. Sci.201819383310.3390/ijms1903083329533978
     [Google Scholar]
  20. PacherP. BátkaiS. KunosG. The endocannabinoid system as an emerging target of pharmacotherapy.Pharmacol. Rev.200658338946210.1124/pr.58.3.216968947
     [Google Scholar]
  21. PacherP. MukhopadhyayP. MohanrajR. GodlewskiG. BátkaiS. KunosG. Modulation of the endocannabinoid system in cardiovascular disease: Therapeutic potential and limitations.Hypertension200852460160710.1161/HYPERTENSIONAHA.105.06365118779440
     [Google Scholar]
  22. Di MarzoV. De PetrocellisL. Why do cannabinoid receptors have more than one endogenous ligand?Philos. Trans. R. Soc. Lond. B Biol. Sci.201236716073216322810.1098/rstb.2011.038223108541
     [Google Scholar]
  23. MurataevaN. StraikerA. MackieK. Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS.Br. J. Pharmacol.201417161379139110.1111/bph.1241124102242
     [Google Scholar]
  24. WittchenH.U. FröhlichC. BehrendtS. GüntherA. RehmJ. ZimmermannP. LiebR. PerkoniggA. Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents.Drug Alcohol Depend.200788Suppl. 1S60S7010.1016/j.drugalcdep.2006.12.01317257779
     [Google Scholar]
  25. BlancoC. HasinD.S. WallM.M. Flórez-SalamancaL. HoertelN. WangS. KerridgeB.T. OlfsonM. Cannabis use and risk of psychiatric disorders.JAMA Psychiatry201673438839510.1001/jamapsychiatry.2015.322926886046
     [Google Scholar]
  26. RadhakrishnanR. WilkinsonS.T. D’SouzaD.C. Gone to pot - A review of the association between cannabis and psychosis.Front. Psychiatry201455410.3389/fpsyt.2014.0005424904437
     [Google Scholar]
  27. BeckerM.P. CollinsP.F. LimK.O. MuetzelR.L. LucianaM. Longitudinal changes in white matter microstructure after heavy cannabis use.Dev. Cogn. Neurosci.201516233510.1016/j.dcn.2015.10.00426602958
     [Google Scholar]
  28. CamchongJ. LimK.O. KumraS. Adverse effects of cannabis on adolescent brain development: A longitudinal study.Cereb. Cortex20172731922193026912785
     [Google Scholar]
  29. AlbaughM.D. Ottino-GonzalezJ. SidwellA. LepageC. JulianoA. OwensM.M. ChaaraniB. SpechlerP. FontaineN. RiouxP. LewisL. JeonS. EvansA. D’SouzaD. RadhakrishnanR. BanaschewskiT. BokdeA.L.W. QuinlanE.B. ConrodP. DesrivièresS. FlorH. GrigisA. GowlandP. HeinzA. IttermannB. MartinotJ.L. Paillère MartinotM.L. NeesF. Papadopoulos OrfanosD. PausT. PoustkaL. MillenetS. FröhnerJ.H. SmolkaM.N. WalterH. WhelanR. SchumannG. PotterA. GaravanH. IMAGEN Consortium Association of cannabis use during adolescence with neurodevelopment.JAMA Psychiatry2021789103110.1001/jamapsychiatry.2021.125834132750
     [Google Scholar]
  30. LorenzettiV. Alonso-LanaS. YoussefG. Verdejo-GarciaA. SuoC. CousijnJ. TakagiM. YücelM. SolowijN. Adolescent cannabis use: What is the evidence for functional brain alteration?Curr. Pharm. Des.201722426353636510.2174/138161282266616080515592227514709
     [Google Scholar]
  31. RaisM. CahnW. Van HarenN. SchnackH. CaspersE. Hulshoff PolH. KahnR. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.Am. J. Psychiatry2008165449049610.1176/appi.ajp.2007.0707111018281413
     [Google Scholar]
  32. KoendersL. MachielsenM.W.J. van der MeerF.J. van GasseltA.C.M. MeijerC.J. van den BrinkW. KoeterM.W.J. CaanM.W.A. CousijnJ. BraberA. van ’t EntD. RiveM.M. ScheneA.H. van de GiessenE. HuyserC. de KwaastenietB.P. VeltmanD.J. de HaanL. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.J. Psychiatry Neurosci.201540319720610.1503/jpn.14008125510948
     [Google Scholar]
  33. YücelM. SolowijN. RespondekC. WhittleS. FornitoA. PantelisC. LubmanD.I. Regional brain abnormalities associated with long-term heavy cannabis use.Arch. Gen. Psychiatry200865669470110.1001/archpsyc.65.6.69418519827
     [Google Scholar]
  34. ScottJ.C. RosenA.F.G. MooreT.M. RoalfD.R. SatterthwaiteT.D. CalkinsM.E. RuparelK. GurR.E. GurR.C. Cannabis use in youth is associated with limited alterations in brain structure.Neuropsychopharmacology20194481362136910.1038/s41386‑019‑0347‑230780151
     [Google Scholar]
  35. DragtS. NiemanD.H. BeckerH.E. van de FliertR. DingemansP.M. de HaanL. van AmelsvoortT.A. LinszenD.H. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.Can. J. Psychiatry201055316517110.1177/07067437100550030820370967
     [Google Scholar]
  36. BeggiatoS. BorelliA.C. TomasiniM.C. MorganoL. AntonelliT. TanganelliS. CuomoV. FerraroL. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ9-THC exposure.Neurobiol. Learn. Mem.201713913514310.1016/j.nlm.2016.12.02328104530
     [Google Scholar]
  37. StiglickA. LlewellynM.E. KalantH. Residual effects of prolonged cannabis treatment on shuttle-box avoidance in the rat.Psychopharmacology198484447647910.1007/BF004314526441947
     [Google Scholar]
  38. ScottJ.C. WolfD.H. CalkinsM.E. BachE.C. WeidnerJ. RuparelK. MooreT.M. JonesJ.D. JacksonC.T. GurR.E. GurR.C. Cognitive functioning of adolescent and young adult cannabis users in the Philadelphia neurodevelopmental cohort.Psychol. Addict. Behav.201731442343410.1037/adb000026828414475
     [Google Scholar]
  39. YücelM. LorenzettiV. SuoC. ZaleskyA. FornitoA. TakagiM.J. LubmanD.I. SolowijN. Hippocampal harms, protection and recovery following regular cannabis use.Transl. Psychiatry201661e71010.1038/tp.2015.20126756903
     [Google Scholar]
  40. WolfS.A. Bick-SanderA. FabelK. Leal-GaliciaP. TauberS. Ramirez-RodriguezG. MüllerA. MelnikA. WaltingerT.P. UllrichO. KempermannG. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.Cell Commun. Signal.2010811210.1186/1478‑811X‑8‑1220565726
     [Google Scholar]
  41. EspositoG. ScuderiC. ValenzaM. TognaG.I. LatinaV. De FilippisD. CiprianoM. CarratùM.R. IuvoneT. SteardoL. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.PLoS One2011612e2866810.1371/journal.pone.002866822163051
     [Google Scholar]
  42. MilichR. LynamD. ZimmermanR. LoganT.K. MartinC. LeukefeldC. PortisC. MillerJ. ClaytonR. Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users.J. Subst. Abuse2000111698810.1016/S0899‑3289(99)00021‑810756515
     [Google Scholar]
  43. BolanisD. OrriM. Castellanos-RyanN. RenaudJ. MontreuilT. BoivinM. VitaroF. TremblayR.E. TureckiG. CôtéS.M. SéguinJ.R. GeoffroyM.C. Cannabis use, depression and suicidal ideation in adolescence: Direction of associations in a population based cohort.J. Affect. Disord.20202741076108310.1016/j.jad.2020.05.13632663935
     [Google Scholar]
  44. BovassoG.B. Cannabis abuse as a risk factor for depressive symptoms.Am. J. Psychiatry2001158122033203710.1176/appi.ajp.158.12.203311729021
     [Google Scholar]
  45. HayatbakhshM.R. NajmanJ.M. JamrozikK. MamunA.A. AlatiR. BorW. Cannabis and anxiety and depression in young adults: A large prospective study.J. Am. Acad. Child Adolesc. Psychiatry200746340841710.1097/chi.0b013e31802dc54d17314727
     [Google Scholar]
  46. DegenhardtL. HallW. LynskeyM. Exploring the association between cannabis use and depression.Addiction200398111493150410.1046/j.1360‑0443.2003.00437.x14616175
     [Google Scholar]
  47. HarderV.S. StuartE.A. AnthonyJ.C. Adolescent cannabis problems and young adult depression: Male-female stratified propensity score analyses.Am. J. Epidemiol.2008168659260110.1093/aje/kwn18418687663
     [Google Scholar]
  48. ConnorJ.P. StjepanovićD. Le FollB. HochE. BudneyA.J. HallW.D. Cannabis use and cannabis use disorder.Nat. Rev. Dis. Primers2021711610.1038/s41572‑021‑00247‑433627670
     [Google Scholar]
  49. DellingF.N. VittinghoffE. DewlandT.A. PletcherM.J. OlginJ.E. NahG. AschbacherK. FangC.D. LeeE.S. FanS.M. KaziD.S. MarcusG.M. Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.BMJ Open201995e02743210.1136/bmjopen‑2018‑02743231092662
     [Google Scholar]
  50. KarilaL. RouxP. RollandB. BenyaminaA. ReynaudM. AubinH.J. LançonC. Acute and long-term effects of cannabis use: A review.Curr. Pharm. Des.201420254112411810.2174/1381612811319999062024001294
     [Google Scholar]
  51. FergussonD.M. HorwoodL.J. Does cannabis use encourage other forms of illicit drug use?Addiction200095450552010.1046/j.1360‑0443.2000.9545053.x10829327
     [Google Scholar]
  52. MorralA.R. McCaffreyD.F. PaddockS.M. Reassessing the marijuana gateway effect.Addiction200297121493150410.1046/j.1360‑0443.2002.00280.x12472629
     [Google Scholar]
  53. HallW.D. LynskeyM. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.Drug Alcohol Rev.2005241394810.1080/0959523050012669816191720
     [Google Scholar]
  54. YamaguchiK. KandelD.B. Patterns of drug use from adolescence to young adulthood: III. Predictors of progression.Am. J. Public Health198474767368110.2105/AJPH.74.7.6736742253
     [Google Scholar]
  55. WagnerF.A. AnthonyJ.C. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine.Am. J. Epidemiol.20021551091892510.1093/aje/155.10.91811994231
     [Google Scholar]
  56. Secades-VillaR. Garcia-RodríguezO. JinC.J. WangS. BlancoC. Probability and predictors of the cannabis gateway effect: A national study.Int. J. Drug Policy201526213514210.1016/j.drugpo.2014.07.01125168081
     [Google Scholar]
  57. FergussonD.M. BodenJ.M. HorwoodL.J. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis.Addiction2006101455656910.1111/j.1360‑0443.2005.01322.x16548935
     [Google Scholar]
  58. FriedmanA.L. MeuriceC. JutkiewiczE.M. Effects of adolescent Δ9-tetrahydrocannabinol exposure on the behavioral effects of cocaine in adult Sprague–Dawley rats.Exp. Clin. Psychopharmacol.201927432633710.1037/pha000027630932503
     [Google Scholar]
  59. LeccaD. ScifoA. PisanuA. ValentiniV. PirasG. SilA. CadoniC. Di ChiaraG. Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction.Neuropharmacology202016610797410.1016/j.neuropharm.2020.10797432007624
     [Google Scholar]
  60. van LeeuwenA.P. VerhulstF.C. ReijneveldS.A. VolleberghW.A.M. OrmelJ. HuizinkA.C. Can the gateway hypothesis, the common liability model and/or, the route of administration model predict initiation of cannabis use during adolescence? A survival analysis--the TRAILS study.J. Adolesc. Health2011481737810.1016/j.jadohealth.2010.05.00821185527
     [Google Scholar]
  61. AgrawalA. LynskeyM.T. Tobacco and cannabis co-occurrence: Does route of administration matter?Drug Alcohol Depend.2009991-324024710.1016/j.drugalcdep.2008.08.00718926646
     [Google Scholar]
  62. HuizinkA.C. LevälahtiE. KorhonenT. DickD.M. PulkkinenL. RoseR.J. KaprioJ. Tobacco, cannabis, and other illicit drug use among Finnish adolescent twins: causal relationship or correlated liabilities?J. Stud. Alcohol Drugs201071151410.15288/jsad.2010.71.520105408
     [Google Scholar]
  63. FergussonD.M. BodenJ.M. Cannabis use and later life outcomes.Addiction2008103696997610.1111/j.1360‑0443.2008.02221.x18482420
     [Google Scholar]
  64. LorenzettiV. HochE. HallW. Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence.Eur. Neuropsychopharmacol.20203616918010.1016/j.euroneuro.2020.03.01232268974
     [Google Scholar]
  65. LynskeyM. HallW. The effects of adolescent cannabis use on educational attainment: A review.Addiction200095111621163010.1046/j.1360‑0443.2000.951116213.x11219366
     [Google Scholar]
  66. PaculaR.L. ChriquiJ.F. ReichmannD.A. Terry-McElrathY.M. State medical marijuana laws: Understanding the laws and their limitations.J. Public Health Policy200223441343910.2307/334324012532682
     [Google Scholar]
  67. FriedP. WatkinsonB. GrayR. Neurocognitive consequences of marihuana—a comparison with pre-drug performance.Neurotoxicol. Teratol.200527223123910.1016/j.ntt.2004.11.00315734274
     [Google Scholar]
  68. MokryszC. LandyR. GageS.H. MunafòM.R. RoiserJ.P. CurranH.V. Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study.J. Psychopharmacol.201630215916810.1177/026988111562224126739345
     [Google Scholar]
  69. MeierM.H. CaspiA. AmblerA. HarringtonH. HoutsR. KeefeR.S.E. McDonaldK. WardA. PoultonR. MoffittT.E. Persistent cannabis users show neuropsychological decline from childhood to midlife.Proc. Natl. Acad. Sci. USA201210940E2657E266410.1073/pnas.120682010922927402
     [Google Scholar]
  70. HorwoodL.J. FergussonD.M. HayatbakhshM.R. NajmanJ.M. CoffeyC. PattonG.C. SilinsE. HutchinsonD.M. Cannabis use and educational achievement: Findings from three Australasian cohort studies.Drug Alcohol Depend.2010110324725310.1016/j.drugalcdep.2010.03.00820456872
     [Google Scholar]
  71. DegenhardtL. CoffeyC. CarlinJ.B. SwiftW. MooreE. PattonG.C. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia.Br. J. Psychiatry2010196429029510.1192/bjp.bp.108.05695220357305
     [Google Scholar]
  72. SwaimR.C. BeauvaisF. ChavezE.L. OettingE.R. The effect of school dropout rates on estimates of adolescent substance use among three racial/ethnic groups.Am. J. Public Health1997871515510.2105/AJPH.87.1.519065226
     [Google Scholar]
  73. FergussonD.M. HorwoodL.J. BeautraisA.L. Cannabis and educational achievement.Addiction200398121681169210.1111/j.1360‑0443.2003.00573.x14651500
     [Google Scholar]
  74. VerweijK.J.H. HuizinkA.C. AgrawalA. MartinN.G. LynskeyM.T. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability?Drug Alcohol Depend.2013133258058610.1016/j.drugalcdep.2013.07.03423972999
     [Google Scholar]
  75. Lynne-LandsmanS.D. LivingstonM.D. WagenaarA.C. Effects of state medical marijuana laws on adolescent marijuana use.Am. J. Public Health201310381500150610.2105/AJPH.2012.30111723763418
     [Google Scholar]
  76. McKennaG.J. The current status of medical marijuana in the United States.Hawaii J. Med. Public Health201473410510824765557
     [Google Scholar]
  77. HoffmannD.E. WeberE. Medical marijuana and the law.N. Engl. J. Med.2010362161453145710.1056/NEJMp100069520410512
     [Google Scholar]
  78. MeadA. Legal and regulatory issues governing cannabis and cannabis-derived products in the United States.Front. Plant Sci.20191069710.3389/fpls.2019.0069731263468
     [Google Scholar]
  79. GhoshT.S. VigilD.I. MaffeyA. TolliverR. Van DykeM. KattariL. KrugH. ReedJ.K. WolkL. Lessons learned after three years of legalized, recreational marijuana: The Colorado experience.Prev. Med.20171044610.1016/j.ypmed.2017.02.02128232101
     [Google Scholar]
  80. RyanJ.E. McCabeS.E. BoydC.J. Medicinal cannabis: Policy, patients, and providers.Policy Polit. Nurs. Pract.202122212613310.1177/152715442198960933567970
     [Google Scholar]
  81. State Medical Cannabis Laws.National Conference of State Legislatures2022
     [Google Scholar]
  82. Yashar EshraghiD.D. Cannabis Regulations.In: Cannabinoids and Pain202191410.1007/978‑3‑030‑69186‑8_2
     [Google Scholar]
  83. McMichaelB.J. Van HornR.L. ViscusiW.K. The impact of cannabis access laws on opioid prescribing.J. Health Econ.20206910227310.1016/j.jhealeco.2019.10227331865260
     [Google Scholar]
  84. VyasM.B. LeBaronV.T. GilsonA.M. The use of cannabis in response to the opioid crisis: A review of the literature.Nurs. Outlook2018661566510.1016/j.outlook.2017.08.01228993073
     [Google Scholar]
  85. BradfordA.C. BradfordW.D. AbrahamA. Bagwell AdamsG. Association between us state medical cannabis laws and opioid prescribing in the medicare part d population.JAMA Intern. Med.2018178566767210.1001/jamainternmed.2018.026629610897
     [Google Scholar]
  86. KnishkowyB. Medical cannabis for pain in adolescence.J. Pain Manag.201694415421
     [Google Scholar]
  87. HopferC. Implications of marijuana legalization for adolescent substance use.Subst. Abus.201435433133510.1080/08897077.2014.94338625127003
     [Google Scholar]
  88. CilG. WintersK.C. AustinS.C. KittelmanA. SmolkowskiK. WestlingE. SeeleyJ.R. Legalization and retail availability of recreational marijuana and adolescent use in schools.Health Econ.2023hec.476310.1002/hec.476337801408
     [Google Scholar]
  89. MennisJ. StahlerG.J. McKeonT.P. Criminal justice referrals to cannabis use disorder treatment among adolescents and young adults following recreational cannabis legalization in the United States.J. Addict. Med.202317672572810.1097/ADM.000000000000121937934545
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775273727231224185028
Loading
Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review
Current Drug Research Reviews 17, 160 (2025); https://doi.org/10.2174/0125899775273727231224185028
/content/journals/cdrr/10.2174/0125899775273727231224185028
/content/journals/cdrr/10.2174/0125899775273727231224185028
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Adolescence; brain; cannabinoid receptor; cannabis; legalization; substance use

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test